- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06335446
Identification, Electro-mechanical Characterisation and Ablation of Driver Regions in Persistent Atrial Fibrillation
Identification, Electro-mechanical Characterisation and Ablation of Driver Regions in Persistent Atrial Fibrillation (STAR Mapping)
Atrial fibrillation (AF) is the most common sustained heart rhythm abnormality. Its incidence is increasing partly due to the aging population and it has been referred to as a growing epidemic. AF results in irregular contractions of the heart causing unpleasant symptoms of palpitations and increasing the risk of stroke, heart failure and death. Percutaneous catheter ablation is a safe treatment option in symptomatic patients with AF. The success rate of these procedures have improved with time due to our better understanding of AF, development of new techniques and technology, and greater physician experience. However, the success rate of these procedures still only remains around 70%. This is secondary to our limited ability to find the areas that drive AF.
STAR mapping is a novel mapping system that has been developed with a view of better identifying the sites that drive AF through taking into account the mechanisms of AF we have so far demonstrated. To validate this mapping system we aim to use it in patients with atrial tachycardia (AT), which is a heart rhythm abnormality of which the mechanism can be readily identified with the existing mapping systems used in clinical practice. We will demonstrate that the STAR mapping algorithm can effectively map AT.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
AT is a heart rhythm that currently can be effectively mapped and ablated using existing mapping systems. The mechanism of this heart rhythm is well understood.
Patients that are scheduled for a catheter ablation for AT by their Electrophysiologist will be enrolled into the study. The patient will have the procedure under local anaesthetics/sedation or general anaesthetic depending on their clinical need.
During the procedure tubes will be passed into the left upper chamber of the heart through the groin. Through these tubes catheters will be used to create a geometry of the heart chamber. Following this, in half of the patients a basket catheter with 64 electrodes will be positioned in the upper chamber whilst conventional catheters will be used in the other half of the patients. The aim of this is to demonstrate that the STAR mapping can be used with multiple mapping catheters. Signals i.e. electrograms will then be collected and used with the STAR mapping algorithm. The AT will then be effectively mapped and ablated with a conventional mapping system. The STAR mapping will then be used for post processing after the case to map the AT and will be compared to the maps generated by the conventional system. This will enable validation of the STAR mapping system.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, EC1A 7BE
- Barts Heart Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients able to provide informed consent
- Patients with AT (whether de novo or occurring post AF ablation)
Exclusion Criteria:
- Unwillingness to sign consent
- Age <18 years old
- Contraindications for catheter ablation procedure
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Atrial tachycardia- validation phase
The group will consist of patients with AT (whether de novo or occurring post AF ablation) that are undergoing catheter ablation.
|
Signals will be collected during the catheter ablation.
These signals STAR maps will be created post procedure and these will be compared to the conventional maps used during the atrial tachycardia ablation.
This will be used to validate the STAR maps created.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
STAR maps compared to conventional maps
Time Frame: At procedure
|
The STAR maps demonstrating the source of the AT correlate with the maps created by the conventional mapping system.
|
At procedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 011040- AT validation phase
- PG/16/10/32016 (Other Grant/Funding Number: British Heart Foundation)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Tachycardia
-
St. George's Hospital, LondonRecruitingAtrial Fibrillation | Ventricular Tachycardia | Atrial Tachycardia | WpwUnited Kingdom
-
Qilu Hospital of Shandong UniversityNot yet recruitingAtrial Fibrillation | Atrial Flutter | Premature Ventricular Contraction | Atrial Tachycardia | Tachyarrhythmia | Paroxysmal Supraventricular Tachycardia
-
Institute for Clinical and Experimental MedicineRecruitingAtrial Fibrillation | Atrial Flutter | Atrial Tachycardia | Atrial ArrhythmiaCzechia
-
Tulane UniversityRecruitingAtrial Fibrillation | Atrial Flutter | Atrial Tachycardia | Atrial ArrhythmiaUnited States
-
Universitätsklinikum Hamburg-EppendorfRecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Ventricular Tachycardia | Atrial Flutter | Supraventricular Tachycardia | Brugada Syndrome | Atrial Tachycardia | Torsades de Pointes | Long QT Syndrome | Arrhythmogenic Right Ventricular Dysplasia | Catecholaminergic Polymorphic Ventricular Tachycardia | Atrial CardiomyopathyGermany
-
Biosense Webster, Inc.CompletedVentricular Tachycardia | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Scar-related Atrial Tachycardia | Premature Ventricular ComplexCroatia, Italy, Israel
-
Biosense Webster, Inc.CompletedVentricular Tachycardia | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Scar-related Atrial Tachycardia | Premature Ventricular ComplexCroatia, Belgium, Italy
-
Ablacon, Inc.RecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia
-
Stanford UniversityCompletedAtrial Fibrillation | Arrhythmias, Cardiac | Atrial Flutter | Atrial TachycardiaUnited States
-
The Hospital for Sick ChildrenLabatt Family Heart CentreRecruitingAtrial Flutter | Tachycardia, Supraventricular | Tachycardia, Atrioventricular Nodal Reentry | Tachycardia Atrial | Tachycardia, Reciprocating | Tachycardia, Paroxysmal | Fetal Hydrops | Tachycardia, Atrial EctopicUnited States, Hong Kong, Canada, Netherlands, Sweden, Australia, Brazil, Finland, France, Russian Federation, Spain, Czechia, Switzerland, United Kingdom
Clinical Trials on Novel mapping algorithm
-
Barts & The London NHS TrustCompletedAtrial FibrillationUnited Kingdom
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); University of NebraskaRecruitingNeonatal Disease | Sleep Disturbance in Infancy (Disorder)United States
-
Rhythm AI LtdBiosense Webster, Inc.WithdrawnAtrial Fibrillation
-
Ablacon, Inc.CompletedArrhythmias, Cardiac | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Longstanding Persistent Atrial FibrillationGermany
-
University of ArizonaUnknown
-
Cardiovascular Research Society, GreeceJohns Hopkins UniversityNot yet recruitingTachycardia, Atrioventricular Nodal Reentry
-
University Hospital Southampton NHS Foundation...Boston Scientific Corporation; AbbottRecruiting
-
IRCCS Ospedale San RaffaeleNot yet recruiting
-
M.D. Anderson Cancer CenterWithdrawn